Artiva Biotherapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 9.85 M | $29.56 M | 0.00% | 40.48% |
5AM VENTURE MANAGEMENT, LLC | 05/15/2025 | 2.35 M | $7.06 M | 0.00% | 9.67% |
VR ADVISER, LLC | 05/15/2025 | 1.61 M | $4.83 M | 0.00% | 6.61% |
BLACKROCK, INC. | 05/02/2025 | 1.25 M | $3.74 M | 19.03% | 5.12% |
VENBIO PARTNERS LLC | 05/15/2025 | 1.20 M | $3.60 M | -21.12% | 4.93% |
CAPITAL WORLD INVESTORS | 05/12/2025 | 866.62 K | $2.60 M | -5.33% | 3.56% |
VANGUARD GROUP INC | 05/09/2025 | 858.21 K | $2.57 M | -1.00% | 3.53% |
FRANKLIN RESOURCES INC | 05/13/2025 | 520.33 K | $1.56 M | 0.01% | 2.14% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 410.46 K | $1.23 M | 29.99% | 1.69% |
SAMSARA BIOCAPITAL, LLC | 05/15/2025 | 291.67 K | $875.00 K | 0.00% | 1.20% |
WOODLINE PARTNERS LP | 05/15/2025 | 283.12 K | $849.37 K | 0.00% | 1.16% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 194.11 K | $582.32 K | 0.00% | 0.80% |
STATE STREET CORP | 05/15/2025 | 171.78 K | $515.35 K | 4.25% | 0.71% |
CITADEL ADVISORS LLC | 05/15/2025 | 145.09 K | $435.27 K | 40.00% | 0.60% |
LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 145.09 K | $435.27 K | 0.00% | 0.60% |
NORTHERN TRUST CORP | 05/13/2025 | 141.68 K | $425.03 K | 20.97% | 0.58% |
ALYESKA INVESTMENT GROUP, L.P. | 05/15/2025 | 100.00 K | $300.00 K | 0.00% | 0.41% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 54.88 K | $164.64 K | 26.09% | 0.23% |
05/12/2025 | 47.89 K | $143.68 K | 100.00% | 0.20% | |
ACUTA CAPITAL PARTNERS, LLC | 05/15/2025 | 45.46 K | $136.37 K | 3.31% | 0.19% |
UBS GROUP AG | 05/13/2025 | 43.08 K | $129.23 K | 21.76% | 0.18% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 41.95 K | $125.86 K | 10.20% | 0.17% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 33.31 K | $99.92 K | 0.00% | 0.14% |
SEI INVESTMENTS CO | 05/14/2025 | 29.28 K | $87.84 K | 100.00% | 0.12% |
MORGAN STANLEY | 05/15/2025 | 27.82 K | $83.46 K | -25.39% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 24.36 K | $73.07 K | 100.00% | 0.10% |
BARCLAYS PLC | 05/15/2025 | 22.75 K | $68.00 K | -5.83% | 0.09% |
DEUTSCHE BANK AG\ | 05/09/2025 | 21.42 K | $64.27 K | 0.00% | 0.09% |
JPMORGAN CHASE & CO | 05/12/2025 | 17.88 K | $53.65 K | -52.46% | 0.07% |
RHUMBLINE ADVISERS | 05/29/2025 | 14.49 K | $43.48 K | 12.53% | 0.06% |
CITIGROUP INC | 05/12/2025 | 14.34 K | $43.01 K | -8.13% | 0.06% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 13.23 K | $39.69 K | 33.92% | 0.05% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 12.66 K | $37.98 K | 46.92% | 0.05% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 11.55 K | $34.64 K | 100.00% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 11.48 K | $34.43 K | 42.77% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 9.74 K | $29.21 K | 33.60% | 0.04% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 8.30 K | $24.89 K | -23.31% | 0.03% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 04/30/2025 | 4.87 K | $14.62 K | -5.40% | 0.02% |
FMR LLC | 05/12/2025 | 3.56 K | $10.67 K | 295.00% | 0.01% |
05/09/2025 | 3.48 K | $10.43 K | 0.00% | 0.01% | |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 2.94 K | $9.00 K | 0.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.61 K | $7.84 K | 115.68% | 0.01% |
LEGAL & GENERAL GROUP PLC | 05/15/2025 | 2.02 K | $6.05 K | 44.87% | 0.01% |
AMERITAS INVESTMENT PARTNERS, INC. | 05/12/2025 | 1.42 K | $4.27 K | 0.00% | 0.01% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 05/15/2025 | 1.04 K | $3.12 K | 0.00% | 0.00% |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 04/24/2025 | 813 | $2.57 K | 0.49% | 0.00% |
04/29/2025 | 603 | $1.81 K | 18.24% | 0.00% | |
AMALGAMATED BANK | 04/25/2025 | 480 | $1.00 K | 0.00% | 0.00% |
ROYAL BANK OF CANADA | 05/15/2025 | 478 | $1.00 K | -56.78% | 0.00% |
MARK SHEPTOFF FINANCIAL PLANNING, LLC | 05/13/2025 | 400 | $1.20 K | -55.56% | 0.00% |
Artiva Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 58 institutional investors and hedge funds held shares of Artiva Biotherapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 9.85 M
5AM Venture Management, LLC: 2.35 M
VR Adviser, LLC: 1.61 M
BlackRock, Inc.: 1.25 M
venBio Partners LLC: 1.2 M
Capital World Investors: 866,622
85.94% of Artiva Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 20.92 M shares in the last 24 months. This purchase volume represents approximately $45.18 M in transactions.